Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1346940

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1346940

Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032

PUBLISHED:
PAGES: 118 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The global human milk oligosaccharides (HMO) market size is expected to reach USD 1,799.96 million by 2032, according to a new study by Polaris Market Research. The report "Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2'FL, 3'FL, 3'SL, 6'SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Human Milk Oligosaccharides (HMOs) are complex carbohydrates or sugars naturally found in human breast milk. HMOs are unique to human milk and are not present in significant amounts in other mammalian milk, including cow's milk.

HMOs serve as a source of infant nutrition, although the baby does not directly digest them. Instead, they act as prebiotics, which means they serve as food for beneficial bacteria in the infant's gut. The gut microbiota is crucial in immune system development, digestion, and overall health. HMOs selectively promote the growth of specific beneficial bacteria, such as Bifidobacteria, while inhibiting the growth of harmful pathogens.

Human Milk Oligosaccharides (HMOs) are essential constituents of human breast milk and are available in various concentrations and compositions. The unique nature of HMOs requires specific regulatory approvals for their use. In the United States, oligosaccharides are authorized to be incorporated into food products rather than categorized as dietary supplements and are subject to the Generally Recognized as Safe (GRAS) regulations.

For instance, the GRAS-approved HMO product line is CARE4U, developed by DuPont, which is utilized in infant formula and toddler foods. This approval ensures its safety for consumption. Furthermore, the growing demand for HMOs has led to a novel food safety assessment to seek support from the European Commission for their usage.

The global adoption of Human Milk Oligosaccharides (HMOs) has increased. According to a World Economic Forum article published in January 2022, the number of births in Japan decreased by 2.8% in 2020 compared to the previous year, reaching its lowest point since 1899.

The increasing demand for HMOs can be attributed to lifestyle improvements and a growing focus on health and wellness. HMOs are utilized in functional food and beverage products and food supplements to address disorders and mitigate high-risk health conditions. This factor has significantly contributed to the growth of the global HMO industry. However, the high costs associated with HMO products are expected to pose a major challenge to market growth during the forecast period.

The COVID-19 pandemic has had a significant impact on the HMO industry. During the initial phase of the pandemic, there was a surge in demand for HMOs as consumers engaged in panic buying for at-home consumption. It resulted in increased sales of HMOs, considered immune-boosting products.

Human Milk Oligosaccharides (HMO) Market Report Highlights

In 2022, the infant formula segment accounted for the largest market share due to the increasing demand for HMOs in infant formula design. HMOs offer beneficial properties like prebiotic effects, infection prevention, memory enhancement, gut health maintenance, and brain development. These factors drive the demand for HMOs in infant formulas.

In 2022, the drug store or pharmacy segment held the highest market share in the Human Milk Oligosaccharides market and is projected to continue growing. It is primarily due to the segment's focus on attracting and retaining customers amidst rising competition from mail-order retailers and supercenters.

The Asia Pacific region expected to witness significant growth in the Human Milk Oligosaccharides (HMO) market due to growing awareness of the benefits of HMOs in infant nutrition and overall health in the region. As consumers become more health-conscious and seek high-quality nutrition options for their infants, the demand for HMOs is expected to rise.

The global Human Milk Oligosaccharides industry players with a global presence including Elicityl S.A., Abbott Laboratories, Biosynth Carbosynth, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Glycosyn, BASF S.E., Glycom A/S, Nestle Health Science, Neolacta Lifesciences Pvt. Ltd, Royal DSM, Medolac Laboratories, Chr. Hansen Holding A/S, ZuChem, Inbiose NV, and Royal FrieslandCampina N.V.

Polaris Market Research has segmented the human milk oligosaccharides (HMO) market report based on type, application, distribution channel, and region:

Human Milk Oligosaccharides (HMO), Type Outlook (Revenue - USD Million, 2019 - 2032)

  • 2'FL
  • 3'FL
  • 3'SL
  • 6'SL

Human Milk Oligosaccharides (HMO), Application Outlook (Revenue - USD Million, 2019 - 2032)

  • Infant Formula
  • Functional Food & Beverage
  • Food Supplements

Human Milk Oligosaccharides (HMO), Distribution Channel Outlook (Revenue - USD Million, 2019 - 2032)

  • Hypermarkets & Supermarkets
  • Drug Store or Pharmacy
  • Online Sales Channel
  • Others

Fogless Mirror, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa
Product Code: PM2516

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Milk Oligosaccharides (HMO) Market Insights

  • 4.1. Human Milk Oligosaccharides (HMO) - Industry Snapshot
  • 4.2. Human Milk Oligosaccharides (HMO) Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increase in the infant population
      • 4.2.1.2. Growing awareness of the importance of breastfeeding
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Limited availability
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Human Milk Oligosaccharides (HMO) Market Industry Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Human Milk Oligosaccharides (HMO) Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • 5.3. 2'FL
    • 5.3.1. Global Human Milk Oligosaccharides (HMO) Market, by 2'FL, by Region, 2019 - 2032 (USD Million)
  • 5.4. 3'FL
    • 5.4.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'FL, by Region, 2019 - 2032 (USD Million)
  • 5.5. 3'SL
    • 5.5.1. Global Human Milk Oligosaccharides (HMO) Market, by 3'SL, by Region, 2019 - 2032 (USD Million)
  • 5.6. 6'SL
    • 5.6.1. Global Human Milk Oligosaccharides (HMO) Market, by 6'SL, by Region, 2019 - 2032 (USD Million)

6. Global Human Milk Oligosaccharides (HMO) Market, by Application

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 6.3. Infant Formula
    • 6.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Infant Formula, by Region, 2019 - 2032 (USD Million)
  • 6.4. Functional Food & Beverage
    • 6.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Functional Food & Beverage, by Region, 2019 - 2032 (USD Million)
  • 6.5. Food Supplements
    • 6.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Food Supplements, by Region, 2019 - 2032 (USD Million)

7. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • 7.3. Hypermarkets & Supermarkets
    • 7.3.1. Global Human Milk Oligosaccharides (HMO) Market, by Hypermarkets & Supermarkets, by Region, 2019 - 2032 (USD Million)
  • 7.4. Drug Store or Pharmacy
    • 7.4.1. Global Human Milk Oligosaccharides (HMO) Market, by Drug Store or Pharmacy, by Region, 2019 - 2032 (USD Million)
  • 7.5. Online Sales Channel
    • 7.5.1. Global Human Milk Oligosaccharides (HMO) Market, by Online Sales Channel, by Region, 2019 - 2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Human Milk Oligosaccharides (HMO) Market, by Others, by Region, 2019 - 2032 (USD Million)

8. Global Human Milk Oligosaccharides (HMO) Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • 8.3. Human Milk Oligosaccharides (HMO) Market - North America
    • 8.3.1. North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.3.2. North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.3.3. North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.4. Human Milk Oligosaccharides (HMO) Market - U.S.
      • 8.3.4.1. U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.4.2. U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.4.3. U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.3.5. Human Milk Oligosaccharides (HMO) Market - Canada
      • 8.3.5.1. Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.3.5.2. Canada.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.3.5.3. Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.4. Human Milk Oligosaccharides (HMO) Market - Europe
    • 8.4.1. Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.4.2. Europe.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.4.3. Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.4. Human Milk Oligosaccharides (HMO) Market - UK
      • 8.4.4.1. UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.4.2. UK.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.4.3. UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.5. Human Milk Oligosaccharides (HMO) Market - France
      • 8.4.5.1. France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.5.2. France.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.5.3. France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.6. Human Milk Oligosaccharides (HMO) Market - Germany
      • 8.4.6.1. Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.6.2. Germany.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.6.3. Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.7. Human Milk Oligosaccharides (HMO) Market - Italy
      • 8.4.7.1. Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.7.2. Italy.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.7.3. Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.8. Human Milk Oligosaccharides (HMO) Market - Spain
      • 8.4.8.1. Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.8.2. Spain.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.8.3. Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.9. Human Milk Oligosaccharides (HMO) Market - Netherlands
      • 8.4.9.1. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.9.2. Netherlands.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.9.3. Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.4.10. Human Milk Oligosaccharides (HMO) Market - Russia
      • 8.4.10.1. Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.4.10.2. Russia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.4.10.3. Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.5. Human Milk Oligosaccharides (HMO) Market - Asia Pacific
    • 8.5.1. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.5.2. Asia Pacific.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.5.3. Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.4. Human Milk Oligosaccharides (HMO) Market - China
      • 8.5.4.1. China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.4.2. China.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.4.3. China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.5. Human Milk Oligosaccharides (HMO) Market - India
      • 8.5.5.1. India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.5.2. India.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.5.3. India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.6. Human Milk Oligosaccharides (HMO) Market - Malaysia
      • 8.5.6.1. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.6.2. Malaysia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.6.3. Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.7. Human Milk Oligosaccharides (HMO) Market - Japan
      • 8.5.7.1. Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.7.2. Japan.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.7.3. Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.8. Human Milk Oligosaccharides (HMO) Market - Indonesia
      • 8.5.8.1. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.8.2. Indonesia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.8.3. Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.5.9. Human Milk Oligosaccharides (HMO) Market - South Korea
      • 8.5.9.1. South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.5.9.2. South Korea.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.5.9.3. South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.6. Human Milk Oligosaccharides (HMO) Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.6.3. Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.4. Human Milk Oligosaccharides (HMO) Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.5. Human Milk Oligosaccharides (HMO) Market - UAE
      • 8.6.5.1. UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.5.2. UAE.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.5.3. UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.6. Human Milk Oligosaccharides (HMO) Market - Israel
      • 8.6.6.1. Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.6.2. Israel.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.6.3. Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.6.7. Human Milk Oligosaccharides (HMO) Market - South Africa
      • 8.6.7.1. South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.6.7.2. South Africa.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.6.7.3. South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • 8.7. Human Milk Oligosaccharides (HMO) Market - Latin America
    • 8.7.1. Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
    • 8.7.2. Latin America.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
    • 8.7.3. Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.4. Human Milk Oligosaccharides (HMO) Market - Mexico
      • 8.7.4.1. Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.4.2. Mexico.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.4.3. Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.5. Human Milk Oligosaccharides (HMO) Market - Brazil
      • 8.7.5.1. Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.5.2. Brazil.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.5.3. Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
    • 8.7.6. Human Milk Oligosaccharides (HMO) Market - Argentina
      • 8.7.6.1. Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
      • 8.7.6.2. Argentina.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
      • 8.7.6.3. Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Abbott Laboratories
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. BASF S.E
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Biosynth Carbosynth
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Chr. Hansen Holding A/S
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Dextra Laboratories Ltd
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Dupont Nutrition & Biosciences
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Elicityl S.A.
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Glycom A/S
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Glycosyn
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Inbiose NV
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Medolac Laboratories
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Neolacta Lifesciences Pvt. Ltd
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Nestle Health Science
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Royal DSM
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Royal FrieslandCampina N.V
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. ZuChem
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development
Product Code: PM2516

List of Tables

  • Table 1 Global Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 2 Global Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 3 Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 4 Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Table 5 North America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 6 North America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 7 North America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 8 U.S.: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 9 U.S.: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 10 U.S.: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 11 Canada: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 12 Canada: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 13 Canada: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 14 Europe: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 15 Europe: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 16 Europe: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 17 UK: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 18 UK: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 19 UK: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 20 France: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 21 France: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 22 France: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 23 Germany: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 24 Germany: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 25 Germany: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 26 Italy: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 27 Italy: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 28 Italy: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 29 Spain: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 30 Spain: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 31 Spain: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 32 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 33 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 34 Netherlands: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 35 Russia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 36 Russia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 37 Russia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 38 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 39 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 40 Asia Pacific: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 41 China: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 42 China: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 43 China: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 44 India: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 45 India: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 46 India: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 47 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 48 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 49 Malaysia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 50 Japan: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 51 Japan: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 52 Japan: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 53 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 54 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 55 Indonesia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 56 South Korea: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 57 South Korea: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 58 South Korea: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 59 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 60 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 61 Middle East & Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 62 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 63 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 64 Saudi Arabia: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 65 UAE: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 66 UAE: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 67 UAE: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 68 Israel: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 69 Israel: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 70 Israel: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 71 South Africa: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 72 South Africa: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 73 South Africa: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 74 Latin America: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 75 Latin America: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 76 Latin America: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 77 Mexico: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 78 Mexico: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 79 Mexico: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 80 Brazil: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 81 Brazil: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 82 Brazil: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)
  • Table 83 Argentina: Human Milk Oligosaccharides (HMO) Market, by Type, 2019 - 2032 (USD Million)
  • Table 84 Argentina: Human Milk Oligosaccharides (HMO) Market, by Application, 2019 - 2032 (USD Million)
  • Table 85 Argentina: Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2019 - 2032 (USD Million)

List of Figures

  • Figure 1. Global Human Milk Oligosaccharides (HMO) Market, 2019 - 2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Human Milk Oligosaccharides (HMO) Market, by Application, 2023 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Human Milk Oligosaccharides (HMO) Market, by Type, 2023 & 2032 (USD Million)
  • Figure 10. Market by Distribution channel
  • Figure 11. Global Human Milk Oligosaccharides (HMO) Market, by Distribution channel, 2023 & 2032 (USD Million)
  • Figure 12. Human Milk Oligosaccharides (HMO) Market Assessment, By Geography, 2019 - 2032 (USD Million)
  • Figure 13. Strategic Analysis - Human Milk Oligosaccharides (HMO) Market
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!